Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Paulo Fontes, MD
CONTACT
Lead
LyGenesis, Inc.
This safety, tolerability, and efficacy study includes an open-label dose-escalation phase for up to 12 subjects with end-stage liver disease (ESLD).
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted